Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
Heart failure patients are classified by ejection fraction (EF) into distinct groups: heart failure
with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction …
with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction …
Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy
M Knapp, X Tu, R Wu - Acta Pharmacologica Sinica, 2019 - nature.com
Diabetes mellitus is currently a major public health problem. A common complication of
diabetes is cardiac dysfunction, which is recognized as a microvascular disease that leads …
diabetes is cardiac dysfunction, which is recognized as a microvascular disease that leads …
Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways
K Huynh, BC Bernardo, JR McMullen… - Pharmacology & …, 2014 - Elsevier
Cardiovascular disease is the primary cause of morbidity and mortality among the diabetic
population. Both experimental and clinical evidence suggest that diabetic subjects are …
population. Both experimental and clinical evidence suggest that diabetic subjects are …
Lipid use and misuse by the heart
PC Schulze, K Drosatos, IJ Goldberg - Circulation research, 2016 - Am Heart Assoc
The heart utilizes large amounts of fatty acids as energy providing substrates. The
physiological balance of lipid uptake and oxidation prevents accumulation of excess lipids …
physiological balance of lipid uptake and oxidation prevents accumulation of excess lipids …
The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
HC Lee, YL Shiou, SJ Jhuo, CY Chang, PL Liu… - Cardiovascular …, 2019 - Springer
Background Sodium glucose co-transporter 2 inhibitor (SGLT2i), a new class of anti-diabetic
drugs acting on inhibiting glucose resorption by kidneys, is shown beneficial in reduction of …
drugs acting on inhibiting glucose resorption by kidneys, is shown beneficial in reduction of …
Diabetic cardiomyopathy: does the type of diabetes matter?
ME Hölscher, C Bode, H Bugger - International journal of molecular …, 2016 - mdpi.com
In recent years, type 2 diabetes mellitus has evolved as a rapidly increasing epidemic that
parallels the increased prevalence of obesity and which markedly increases the risk of …
parallels the increased prevalence of obesity and which markedly increases the risk of …
Diabetic cardiomyopathy: pathophysiology and clinical features
T Miki, S Yuda, H Kouzu, T Miura - Heart failure reviews, 2013 - Springer
Since diabetic cardiomyopathy was first reported four decades ago, substantial information
on its pathogenesis and clinical features has accumulated. In the heart, diabetes enhances …
on its pathogenesis and clinical features has accumulated. In the heart, diabetes enhances …
Diabetic cardiomyopathy revisited
S Boudina, ED Abel - Circulation, 2007 - Am Heart Assoc
Diabetes mellitus increases the risk of heart failure independently of underlying coronary
artery disease, and many believe that diabetes leads to cardiomyopathy. The underlying …
artery disease, and many believe that diabetes leads to cardiomyopathy. The underlying …
Obesity, diabetes, and cardiovascular diseases: a compendium
PE Scherer, JA Hill - Circulation research, 2016 - Am Heart Assoc
1704 Circulation Research May 27, 2016 of epigenetic mechanisms contributing to
macrovascular disease in diabetes. The authors highlight the recent identification of …
macrovascular disease in diabetes. The authors highlight the recent identification of …
Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications
ZY Fang, JB Prins, TH Marwick - Endocrine reviews, 2004 - academic.oup.com
The presence of a diabetic cardiomyopathy, independent of hypertension and coronary
artery disease, is still controversial. This systematic review seeks to evaluate the evidence …
artery disease, is still controversial. This systematic review seeks to evaluate the evidence …